newsfilter
← Latest News
GlobeNewswire·

Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance

CARLSBAD, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2024. Highlights: